In today’s Pharma Pulse, learn how digital pharmacy safety gaps, Novo Nordisk’s introductory programs for Wegovy and Ozempic, and Scott Gottlieb’s new role at UnitedHealth are shaping patient access ...
Novo Nordisk offers Wegovy and Ozempic at $199/month for new self-pay patients, valid for the first two months until March 31 ...
And finally, urgent care technology company Experity has expanded its partner ecosystem by integrating Amazon Pharmacy into its platform. The move aims to streamline prescription workflows, enabling ...
Ultimately, Khan emphasized that protecting PHI requires more than compliance checkboxes—it demands a continuous, structured ...
You can catch Pharma Pulse directly on Audioboom , Spotify, or iHeart. Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug ...
In third part of his Pharma Commerce video interview, Faisal Khan, a GRC solutions expert with Vanta, emphasizes the need for ...
Submission packages—such as drug master files for active ingredients—are pre-validated by an AI engine, allowing companies to ...
This comes during a time when when Eli Lilly and Novo Nordisk have been garnering momentum—last week, the FDA added ...
Novartis has unveiled a 10,000-square-foot radioligand therapy (RLT) production plant in Carlsbad, CA, representing a move ...
Pharma Pulse: FDA Appoints Richard Pazdur as CDER Director Amid 340B Tensions and Novartis Expansion
This episode of Pharma Pulse discusses how Dr. Richard Pazdur’s appointment signals a new era for FDA drug evaluation, why hospitals are opposing the government’s 340B pilot program, and how Novartis ...
This episode of Pharma Pulse discusses how the FDA’s new plausible mechanism pathway, WeightWatchers’ plans to offer oral Wegovy, and emerging evidence on berberine are shaping the future of obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback